Citi Assumes Guardant Health (GH) at Buy
Tweet
Share
E-mailGet Alerts GH Hot Sheet
Price: $157.21 -1.46%
Rating Summary:
28 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
28 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Citi analyst Brendan Digan assumes coverage on Guardant Health (NASDAQ: GH) with a Buy rating and a price target of $215.00.
For an analyst ratings summary and ratings history on Guardant Health click here. For more ratings news on Guardant Health click here.
Shares of Guardant Health closed at $144.07 yesterday.
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Leerink Starts Ligand Pharma (LGND) at Outperform
- BMO Capital Starts Energy Fuels (UUUU) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
